At Antares Pharma, we are committed to the highest standards of ethical conduct throughout all aspects of our business, including with our employees, customers, suppliers, stockholders and others. We are committed to acting honestly and in compliance with all applicable laws, rules, regulations and corporate policies. Antares Pharma understands that acting responsibly, safely and with sound principles of corporate governance is essential to acquiring and preserving trust with our employees, customers and stockholders. To that end, the Board of Directors adopted a code of conduct and Antares Pharma implemented a Corporate Compliance Program to further its longstanding goal of providing effective governance of Antares Pharma’s business for the long-term benefit of its patients and stockholders.
The Corporate Compliance Program is led by the Chief Compliance Officer and other representatives from various functional areas, who participate as members of the Corporate Compliance Committee.
CORPORATE COMPLIANCE PROGRAM
Antares Pharma has developed an integrated company-wide Corporate Compliance Program designed to promote accountability for legal and ethical responsibilities across all functional areas of Antares Pharma, including Finance, Legal, Human Resources, Regulatory, Quality, Clinical, Research and Development, Business Development, Operations, Manufacturing, Commercial and Marketing. In addition, the Corporate Compliance Program is intended to address the elements of an effective compliance program in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers” developed by the United States Department of Health and Human Services, Office of Inspector General.
Antares Pharma’s current Corporate Compliance Program: DOWNLOAD
For questions about our Comprehensive Compliance Program or to obtain a copy, please contact us at firstname.lastname@example.org.
CALIFORNIA STATEMENT OF COMPLIANCE
It is the policy of Antares Pharma to maintain the highest level of professional and ethical standards in the conduct of its business and to comply with all applicable laws in the United States and in all foreign countries where it operates. To ensure compliance with this policy, the company has adopted a formal Compliance Program in accordance with California Health and Safety Codes §§ 119400-119402 (“California’s Healthcare Compliance Program Requirements”), and, to the best of its knowledge as of January 1, 2021 and based on its good faith understanding of such statutory requirements, declares that it is in compliance with California’s Healthcare Compliance Program Requirements. While even the best compliance program cannot guarantee that individual unethical employees engage in improper or unethical conduct, we believe that our compliance program has been reasonably designed, implemented and enforced with the goal of preventing and detecting such improper conduct. Furthermore, as required by best compliance practices, we continuously and regularly assesses its effectiveness and implement changes or refinements where needed.
CODE OF CONDUCT
The Board of Directors of Antares Pharma adopted the Code of Business Conduct and Ethics which applies to all directors, officers, and employees of Antares Pharma (collectively, “Company Personnel”). The Code of Business Conduct and Ethics was adopted to help these Company Personnel meet standards of ethical conduct and good corporate governance. Specifically, the purpose of this Code of Business Conduct and Ethics is:
- to encourage among Company Personnel a culture of honesty, accountability, and mutual respect;
- to promote compliance with all applicable governmental laws, rules and regulations;
- to provide guidance to help Company Personnel to recognize and deal with ethical issues; and
- to provide mechanisms for Company Personnel to report unethical conduct.
Antares Pharma’s current Code of Business Conduct and Ethics: DOWNLOAD
Other corporate governance documents of Antares Pharma can be found here.
Antares Pharma is committed to complying with applicable anti-bribery and anti-corruption laws, including the United States Foreign Corrupt Practices Act. To support this commitment, Antares Pharma has adopted standards to prevent bribery and corruption in its Code of Business Conduct and Ethics and its Foreign Corrupt Practices Act Compliance Policy, which can be found here: DOWNLOAD
Antares Pharma has established various methods of confidential and non-confidential communication for its employees and others to report concerns about conflicts of interest, ethical concerns, financial fraud or irregularities, violations or suspected violations of laws, rules, policies, regulations, Antares Pharma’s Code of Business Conduct and Ethics, or its Corporate Compliance Program.
Those concerns may be raised on an non-anonymous basis by submitting them in the form of a complaint to email@example.com or (609) 359-3031, which will be monitored by Antares Pharma’s Chief Compliance Officer or a designee.
A complaint may be submitted on a confidential, anonymous basis to Antares Pharma’s “Whistleblower Hotline”. The Whistleblower Hotline is maintained through an outside reporting firm, which can be reached here. Alternatively, a complaint can also be submitted on a confidential, anonymous basis to Antares Pharma’s Audit Committee of the Board of Directors (the “Audit Committee”), send it in a sealed envelope marked clearly as “confidential” to the Chair of the Audit Committee at Antares Pharma’s principal address (as indicated in Antares’ website at www.antarespharma.com).
Additional information regarding these Compliance hotlines and Antares Pharma’s handling of reports of compliance concerns can be found in Antares Pharma’s Corporate Compliance Program and in its Code of Business Conduct and Ethics.